Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,803 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,155 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05187208 | PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer(POLO) | unknown | Phase 4 | 102 | Seoul National University HospitalOTHER | 0 | Jan 26, 2022 | clinicaltrials |
| NCT02726009 | A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer | completed | Phase 4 | 230 | Ferring PharmaceuticalsINDUSTRY | 1 | Dec 15, 2021 |
| NCT03317795 | Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids | completed | Phase 4 | 18 | Shannon K. Laughlin-TommasoOTHER | 1 | Dec 8, 2021 | clinicaltrials |
| NCT05068180 | Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients | unknown | Phase 4 | 200 | RenJi HospitalOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT04910802 | Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden | recruiting | Phase 4 | 150,000 | Miriam ElfströmOTHER_GOV | 1 | Sep 16, 2021 | clinicaltrials |
| NCT01953107 | Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. | completed | Phase 4 | 200 | Sunnybrook Health Sciences CentreOTHER | 1 | May 12, 2021 | clinicaltrials |
| NCT04882618 | Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer. | unknown | Phase 4 | 50 | TC Erciyes UniversityOTHER | 1 | May 12, 2021 | clinicaltrials |
| NCT04832906 | UA Versus UAE in Treatment of Fibroids | completed | Phase 4 | 70 | Ain Shams Maternity HospitalOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT04819685 | Application of KANG FU PEN in Radical Concurrent Radiotherapy and Chemotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Rectal Injury | unknown | Phase 4 | 520 | Peking Union Medical College HospitalOTHER | 1 | Mar 29, 2021 | clinicaltrials |
| NCT01101750 | Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls? | completed | Phase 4 | 25 | Medstar Health Research InstituteOTHER | 1 | Jan 5, 2021 | clinicaltrials |
| NCT01753297 | A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.(PRIORITI) | completed | Phase 4 | 226 | IpsenINDUSTRY | 2 | Dec 9, 2020 | clinicaltrials |
| NCT02721433 | 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases(REaCT-BTA) | completed | Phase 4 | 263 | Ottawa Hospital Research InstituteOTHER | 1 | Dec 2, 2020 | clinicaltrials |
| NCT03423082 | Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer. | terminated | Phase 4 | 1 | Nghi NguyenOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT01738724 | Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin | terminated | Phase 4 | 14 | University of Sao PauloOTHER | 0 | Aug 13, 2020 | clinicaltrials |
| NCT03105856 | FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program(FASTER) | completed | Phase 4 | 3,000 | Instituto Nacional de Salud Publica, MexicoOTHER | 1 | Aug 10, 2020 | clinicaltrials |
| NCT03006562 | PREvention of VENous ThromboEmbolism Following Radical Prostatectomy(PREVENTER) | terminated | Phase 4 | 501 | Johns Hopkins UniversityOTHER | 1 | Aug 5, 2020 | clinicaltrials |
| NCT03543462 | Diaphragmatic Resection And Gynecological Ovarian Neoplasm(DRAGON) | completed | Phase 4 | 88 | Catholic University of the Sacred HeartOTHER | 1 | May 22, 2020 | clinicaltrials |
| NCT04132349 | Ulipristal Acetate in Symptomatic Uterine Fibroid | terminated | Phase 4 | 25 | Mỹ Đức HospitalOTHER | 1 | Apr 13, 2020 | clinicaltrials |
| NCT02812186 | Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery | completed | Phase 4 | 79 | Stony Brook UniversityOTHER | 1 | Apr 8, 2020 | clinicaltrials |
| NCT03349463 | Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. | unknown | Phase 4 | 30 | Bital Savir-BaruchOTHER | 1 | Feb 28, 2020 | clinicaltrials |
| NCT02470741 | Pilot of Letrozole for Uterine Myomas(PLUM) | completed | Phase 4 | 12 | University of California, San FranciscoOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT03210324 | A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy | terminated | Phase 4 | 434 | China Resources Zizhu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 7, 2019 | clinicaltrials |
| NCT02837926 | Comparing Health Services Interventions for the Prevention of HPV-related Cancer(CoheaHr-WP4) | completed | Phase 4 | 63 | CHU de ReimsOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT03793205 | G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients | unknown | Phase 4 | 100 | Lei LiOTHER | 1 | Jan 7, 2019 | clinicaltrials |
| NCT01544478 | V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) | completed | Phase 4 | 1,030 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Nov 28, 2018 | clinicaltrials |
| NCT03752606 | Application of Tachosil During Lymphadenectomy | completed | Phase 4 | 50 | Medical University of LublinOTHER | 1 | Nov 26, 2018 | clinicaltrials |
| NCT01136226 | Evaluate Recovery of Testosterone for Patients Using Eligard(Eligard) | completed | Phase 4 | 42 | Chesapeake Urology Research AssociatesOTHER | 0 | Oct 24, 2018 | clinicaltrials |
| NCT02818816 | Preoperative Brimonidine on IOP of Patients Undergoing RALP(IOPsTBURG) | completed | Phase 4 | 26 | University Health Network, TorontoOTHER | 1 | Sep 27, 2018 | clinicaltrials |
| NCT00859027 | Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer | completed | Phase 4 | 50 | UConn HealthOTHER | 1 | May 1, 2018 | clinicaltrials |
| NCT02441517 | A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment | terminated | Phase 4 | 4 | Astellas Pharma Global Development, Inc.INDUSTRY | 1 | Apr 19, 2018 | clinicaltrials |
| NCT03500367 | Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis | unknown | Phase 4 | 25 | Peking Union Medical College HospitalOTHER | 1 | Apr 18, 2018 | clinicaltrials |
| NCT03384511 | The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. | completed | Phase 4 | 38 | Shandong Cancer Hospital and InstituteOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT02025361 | Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy | completed | Phase 4 | 422 | Bagcilar Training and Research HospitalOTHER_GOV | 1 | Jan 18, 2018 | clinicaltrials |
| NCT00995878 | The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids. | completed | Phase 4 | 56 | Mayo ClinicOTHER | 1 | Jan 12, 2018 | clinicaltrials |
| NCT00666978 | Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | completed | Phase 4 | 540 | Lisa Sanderson Cox, PhDOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT01296672 | 3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer | completed | Phase 4 | 383 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT00063609 | The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy | completed | Phase 4 | 200 | Novartis PharmaceuticalsINDUSTRY | 1 | Sep 13, 2017 | clinicaltrials |
| NCT03206684 | To Evaluate the Efficacy and Safety of PEG-rhG-CSF（Jinyouli®） in Reducing Neutropenia in Patients With Cervical Cancer | unknown | Phase 4 | 20 | Air Force Military Medical University, ChinaOTHER | 1 | Aug 28, 2017 | clinicaltrials |
| NCT03202381 | Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix(BLADE) | unknown | Phase 4 | 35 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Jun 28, 2017 | clinicaltrials |
| NCT00219271 | Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer | completed | Phase 4 | 60 | Novartis PharmaceuticalsINDUSTRY | 1 | May 31, 2017 | clinicaltrials |
| NCT02629510 | The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP)(TACO) | unknown | Phase 4 | 268 | Asan Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT01230905 | Study to Monitor the Effects of Androgen Suppression Treatment on the Heart(AST) | completed | Phase 4 | 181 | Ottawa Heart Institute Research CorporationOTHER | 1 | Apr 24, 2017 | clinicaltrials |
| NCT01432015 | Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting | completed | Phase 4 | 20 | Gynecologic Oncology AssociatesOTHER | 1 | Mar 28, 2017 | clinicaltrials |
| NCT02543710 | Biomarker Guided Treatment in Gynaecological Cancer(Momatec2) | recruiting | Phase 4 | 1,300 | Haukeland University HospitalOTHER | 3 | Mar 28, 2017 | clinicaltrials |
| NCT01933022 | A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the Disease(EFFECT) | terminated | Phase 4 | 1 | Astellas Pharma Europe Ltd.INDUSTRY | 1 | Mar 9, 2017 | clinicaltrials |
| NCT00237146 | Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy | completed | Phase 4 | 38 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00242554 | Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases | completed | Phase 4 | 150 | Novartis PharmaceuticalsINDUSTRY | 0 | Feb 23, 2017 | clinicaltrials |
| NCT00334139 | Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer | completed | Phase 4 | 411 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 7, 2017 | clinicaltrials |
| NCT02441894 | Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer(PEGAZUS) | completed | Phase 4 | 21 | SanofiINDUSTRY | 1 | Jan 24, 2017 | clinicaltrials |
| NCT00375765 | Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer | completed | Phase 4 | 40 | GlaxoSmithKlineINDUSTRY | 1 | Jan 19, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Jan 26, 2022source: clinicaltrials